Back to CVE records
Medium 5.9Published May 19, 2026

CVE-2026-32134NanoMQ: NULL Pointer Dereference Crash in tcptran_pipe_peer During Session Restore

Updated under an hour ago ()

Does this affect you?

It affects nanomq and 1 other product. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

NanoMQ MQTT Broker (NanoMQ) is an all-around Edge Messaging Platform. In versions 0.24.10 and below, when NanoMQ handles high-concurrency reconnect traffic using a reconnect-collision payload, the broker can crash due to a NULL pointer dereference during MQTT session resumption for clean_start=0 clients. The transport's p_peer callback (tcptran_pipe_peer()) iterates cpipe->subinfol while copying session metadata from the cached old pipe to the new reconnecting pipe, without checking whether the pointer is NULL. Under a reconnect race, cpipe->subinfol can be freed and set to NULL before session restore invokes this function, resulting in a remote unauthenticated Denial-of-Service (process crash) condition. This issue has been fixed in version 0.24.11.

CVSS
5.9 MEDIUM (v3.1, CNA)CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:N/I:N/A:H
Weakness (CWE)
CWE-476
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
GitHub_M
NVD analysis
Deferred
Record last updated
May 19, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
nanomq nanomq
nanomq:nanomq (from the name)
before 0.24.11
CNA record
nanomq NanoNNG
nanomq:nanonng (from the name)
before 0.24.11
CNA record

References

References

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.